Cite Filings / ALGS / 0001193125-20-274431

Feed Companies Filings Check

Sign in

SC 13D

Beneficial Ownership Report

Aligos Therapeutics, Inc. Filed 2020-10-22 Acc 0001193125-20-274431

Documents 1

SC 13D Beneficial Ownership Report , d74409dsc13d.htm

Around this filing

2020-10-30 SC 13D Beneficial Ownership Report
2020-10-22 SC 13G Amended Statement of Ownership
2020-10-22 4 10% owner bought 200,000 shares at $15.00 ($3,000,000)
2020-10-22 4 10% owner acquired 1,906,191 shares (conversion)
2020-10-22 SC 13D Beneficial Ownership Report
2020-10-20 4 Director bought 200,000 shares at $15.00 ($3,000,000)
2020-10-20 4 10% owner bought 550,000 shares at $15.00 ($8,250,000)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d74409dsc13d.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…